Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accumulated Depreciation (2016 - 2022)

Historic Accumulated Depreciation for HUTCHMED (China) (HCM) over the last 9 years, with Q4 2022 value amounting to $36.9 million.

  • HUTCHMED (China)'s Accumulated Depreciation rose 1205.2% to $36.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $36.9 million, marking a year-over-year increase of 1205.2%. This contributed to the annual value of $36.9 million for FY2022, which is 1205.2% up from last year.
  • HUTCHMED (China)'s Accumulated Depreciation amounted to $36.9 million in Q4 2022, which was up 1205.2% from $32.9 million recorded in Q4 2021.
  • Over the past 5 years, HUTCHMED (China)'s Accumulated Depreciation peaked at $36.9 million during Q4 2022, and registered a low of $19.8 million during Q4 2018.
  • Over the past 5 years, HUTCHMED (China)'s median Accumulated Depreciation value was $26.3 million (recorded in 2020), while the average stood at $27.8 million.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first surged by 2518.17% in 2021, then skyrocketed by 1205.2% in 2022.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Accumulated Depreciation stood at $19.8 million in 2018, then increased by 17.78% to $23.4 million in 2019, then rose by 12.54% to $26.3 million in 2020, then grew by 25.18% to $32.9 million in 2021, then rose by 12.05% to $36.9 million in 2022.
  • Its Accumulated Depreciation stands at $36.9 million for Q4 2022, versus $32.9 million for Q4 2021 and $26.3 million for Q4 2020.